OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries
Justin Davis, Steven Moylan, Brian H. Harvey, et al.
Australian & New Zealand Journal of Psychiatry (2014) Vol. 48, Iss. 6, pp. 512-529
Closed Access | Times Cited: 148
Justin Davis, Steven Moylan, Brian H. Harvey, et al.
Australian & New Zealand Journal of Psychiatry (2014) Vol. 48, Iss. 6, pp. 512-529
Closed Access | Times Cited: 148
Showing 1-25 of 148 citing articles:
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis
Justin Davis, Harris A. Eyre, Felice N. Jacka, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 65, pp. 185-194
Open Access | Times Cited: 322
Justin Davis, Harris A. Eyre, Felice N. Jacka, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 65, pp. 185-194
Open Access | Times Cited: 322
Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
André F. Carvalho, Beatrice Bortolato, Kamilla Woznica Miskowiak, et al.
Neuropsychiatric Disease and Treatment (2015), pp. 3111-3111
Open Access | Times Cited: 287
André F. Carvalho, Beatrice Bortolato, Kamilla Woznica Miskowiak, et al.
Neuropsychiatric Disease and Treatment (2015), pp. 3111-3111
Open Access | Times Cited: 287
Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications
Ashwini Rajasekaran, Ganesan Venkatasubramanian, Michael Berk, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 48, pp. 10-21
Closed Access | Times Cited: 253
Ashwini Rajasekaran, Ganesan Venkatasubramanian, Michael Berk, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 48, pp. 10-21
Closed Access | Times Cited: 253
Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications
Brisa S. Fernandes, Johann Steiner, Michael Berk, et al.
Molecular Psychiatry (2014) Vol. 20, Iss. 9, pp. 1108-1119
Open Access | Times Cited: 232
Brisa S. Fernandes, Johann Steiner, Michael Berk, et al.
Molecular Psychiatry (2014) Vol. 20, Iss. 9, pp. 1108-1119
Open Access | Times Cited: 232
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Gerwyn Morris, Michael Berk
BMC Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 223
Gerwyn Morris, Michael Berk
BMC Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 223
Nutraceuticals in Neurological Disorders
Rashita Makkar, Tapan Behl, Simona Bungău, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4424-4424
Open Access | Times Cited: 146
Rashita Makkar, Tapan Behl, Simona Bungău, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4424-4424
Open Access | Times Cited: 146
Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review
Błażej Misiak, Filip Stramecki, Łukasz Gawęda, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 6, pp. 5075-5100
Open Access | Times Cited: 150
Błażej Misiak, Filip Stramecki, Łukasz Gawęda, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 6, pp. 5075-5100
Open Access | Times Cited: 150
The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia
Chutima Roomruangwong, Cristiano Noto, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 2, pp. 778-797
Closed Access | Times Cited: 139
Chutima Roomruangwong, Cristiano Noto, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 2, pp. 778-797
Closed Access | Times Cited: 139
High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
Cristiano Noto, Michaël Maes, Vanessa Kiyomi Ota, et al.
The World Journal of Biological Psychiatry (2015) Vol. 16, Iss. 6, pp. 422-429
Closed Access | Times Cited: 103
Cristiano Noto, Michaël Maes, Vanessa Kiyomi Ota, et al.
The World Journal of Biological Psychiatry (2015) Vol. 16, Iss. 6, pp. 422-429
Closed Access | Times Cited: 103
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Gerwyn Morris, Basant K. Puri, Adam J. Walker, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 862-882
Closed Access | Times Cited: 98
Gerwyn Morris, Basant K. Puri, Adam J. Walker, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 862-882
Closed Access | Times Cited: 98
Cognitive effects of adjunctive N-acetyl cysteine in psychosis
Marta Rapado‐Castro, Seetal Dodd, Ashley I. Bush, et al.
Psychological Medicine (2016) Vol. 47, Iss. 5, pp. 866-876
Open Access | Times Cited: 91
Marta Rapado‐Castro, Seetal Dodd, Ashley I. Bush, et al.
Psychological Medicine (2016) Vol. 47, Iss. 5, pp. 866-876
Open Access | Times Cited: 91
Meta-analysis of randomised controlled trials withN-acetylcysteine in the treatment of schizophrenia
Caitlin Yolland, D. Hanratty, Erica Neill, et al.
Australian & New Zealand Journal of Psychiatry (2019) Vol. 54, Iss. 5, pp. 453-466
Closed Access | Times Cited: 86
Caitlin Yolland, D. Hanratty, Erica Neill, et al.
Australian & New Zealand Journal of Psychiatry (2019) Vol. 54, Iss. 5, pp. 453-466
Closed Access | Times Cited: 86
Updating and characterizing neuroanatomical markers in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysis
Donato Liloia, Claudio Brasso, Franco Cauda, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 123, pp. 83-103
Open Access | Times Cited: 61
Donato Liloia, Claudio Brasso, Franco Cauda, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 123, pp. 83-103
Open Access | Times Cited: 61
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset
E. Bulzacka, Laurent Boyer, Franck Schürhoff, et al.
Schizophrenia Bulletin (2016) Vol. 42, Iss. 5, pp. 1290-1302
Open Access | Times Cited: 86
E. Bulzacka, Laurent Boyer, Franck Schürhoff, et al.
Schizophrenia Bulletin (2016) Vol. 42, Iss. 5, pp. 1290-1302
Open Access | Times Cited: 86
Risk of Schizophrenia Increases After All Child and Adolescent Psychiatric Disorders: A Nationwide Study
Cecilie Frejstrup Maibing, Carsten Bøcker Pedersen, Michael E. Benros, et al.
Schizophrenia Bulletin (2014) Vol. 41, Iss. 4, pp. 963-970
Open Access | Times Cited: 78
Cecilie Frejstrup Maibing, Carsten Bøcker Pedersen, Michael E. Benros, et al.
Schizophrenia Bulletin (2014) Vol. 41, Iss. 4, pp. 963-970
Open Access | Times Cited: 78
Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies
Adrian L. Lopresti
Journal of Psychopharmacology (2017) Vol. 31, Iss. 3, pp. 287-302
Closed Access | Times Cited: 75
Adrian L. Lopresti
Journal of Psychopharmacology (2017) Vol. 31, Iss. 3, pp. 287-302
Closed Access | Times Cited: 75
Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia
Marco Solmi, Nicola Veronese, Nita Thapa, et al.
CNS Spectrums (2017) Vol. 22, Iss. 5, pp. 415-426
Open Access | Times Cited: 71
Marco Solmi, Nicola Veronese, Nita Thapa, et al.
CNS Spectrums (2017) Vol. 22, Iss. 5, pp. 415-426
Open Access | Times Cited: 71
Maternal Immune Activation Causes Schizophrenia-like Behaviors in the Offspring through Activation of Immune-Inflammatory, Oxidative and Apoptotic Pathways, and Lowered Antioxidant Defenses and Neuroprotection
Pinku Mani Talukdar, Fazal Abdul, Michaël Maes, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 10, pp. 4345-4361
Closed Access | Times Cited: 66
Pinku Mani Talukdar, Fazal Abdul, Michaël Maes, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 10, pp. 4345-4361
Closed Access | Times Cited: 66
In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype
Michaël Maes, Buranee Kanchanatawan, Sunee Sirivichayakul, et al.
Neurotoxicity Research (2018) Vol. 35, Iss. 3, pp. 684-698
Closed Access | Times Cited: 65
Michaël Maes, Buranee Kanchanatawan, Sunee Sirivichayakul, et al.
Neurotoxicity Research (2018) Vol. 35, Iss. 3, pp. 684-698
Closed Access | Times Cited: 65
Immuno-psychiatry: an agenda for clinical practice and innovative research
Marion Leboyer, Michael Berk, Robert H. Yolken, et al.
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 63
Marion Leboyer, Michael Berk, Robert H. Yolken, et al.
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 63
Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: A systematic review and meta-analysis
Asara Vasupanrajit, Ketsupar Jirakran, Chavit Tunvirachaisakul, et al.
Journal of Affective Disorders (2021) Vol. 295, pp. 80-92
Open Access | Times Cited: 56
Asara Vasupanrajit, Ketsupar Jirakran, Chavit Tunvirachaisakul, et al.
Journal of Affective Disorders (2021) Vol. 295, pp. 80-92
Open Access | Times Cited: 56
Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia
Michaël Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7056-7073
Closed Access | Times Cited: 55
Michaël Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7056-7073
Closed Access | Times Cited: 55
The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders
Gerwyn Morris, Basant K. Puri, Chiara C. Bortolasci, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 244-263
Closed Access | Times Cited: 52
Gerwyn Morris, Basant K. Puri, Chiara C. Bortolasci, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 244-263
Closed Access | Times Cited: 52
N ‐acetylcysteine as a new prominent approach for treating psychiatric disorders
Irena Smaga, Małgorzata Frankowska, Małgorzata Filip
British Journal of Pharmacology (2021) Vol. 178, Iss. 13, pp. 2569-2594
Open Access | Times Cited: 47
Irena Smaga, Małgorzata Frankowska, Małgorzata Filip
British Journal of Pharmacology (2021) Vol. 178, Iss. 13, pp. 2569-2594
Open Access | Times Cited: 47
Therapeutic Approaches of Nutraceuticals in Neurological Disorders: A Review
Vipul Kumar, Harsh K. Gupta, Anamika Anamika, et al.
Journal for Research in Applied Sciences and Biotechnology (2024) Vol. 3, Iss. 2, pp. 261-281
Open Access | Times Cited: 7
Vipul Kumar, Harsh K. Gupta, Anamika Anamika, et al.
Journal for Research in Applied Sciences and Biotechnology (2024) Vol. 3, Iss. 2, pp. 261-281
Open Access | Times Cited: 7
